Skip to main content
HR 3536 115th Congress House Health Drug safety, medical device, and laboratory regulation Health programs administration and funding Health technology, devices, supplies Inflation and prices Intellectual property Medical research Research and development

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Introduced: July 28, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 4, 2017
Referred to the Subcommittee on Health.
Jul 28, 2017
Referred to the House Committee on Energy and Commerce.
Jul 28, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

What's happening now August 4, 2017

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 1681 Identical bill A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pri…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 3
D
Khanna, Ro
California · Jul 11, 2018
 D
Kaptur, Marcy
Ohio · Sep 5, 2017
 D
Schakowsky, Janice D.
Illinois · Sep 5, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3536: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.. 115th Congress. Open America. https://openamerica.io/bill/115-HR-3536/
MLA
"H.R. 3536: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-3536/.
Bluebook (legal)
H.R. 3536, 115th Cong. (2026), https://openamerica.io/bill/115-HR-3536/.
Markdown link
[H.R. 3536: To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.](https://openamerica.io/bill/115-HR-3536/)
Report a problem